Aussie radiopharmaceutical company AdvanCell collects $112 million in Series C financing
SV Health Investors, Sanofi Ventures, Abingworth, and SymBiosis led the round.
SV Health Investors, Sanofi Ventures, Abingworth, and SymBiosis led the round.
Copyright PEI Media
Not for publication, email or dissemination